Medications

FDA: Weight-control drug lorcaserin may raise cancer risk

The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug Administration ...

Medical research

Lower risk for malignant melanoma after bariatric surgery

Bariatric surgery is associated with a distinct reduction in skin-cancer risk, a study shows. This finding can be described as a key piece of evidence that substantiates the connection between weight loss and malignant skin ...

Oncology & Cancer

Incidence of early-onset gastric cancer increasing in the U.S.

(HealthDay)—The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer, according to a study recently published ...

page 1 from 23